Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

May 20, 2025

Merit Medical Acquires Biolife

May 20, 2025—Merit Medical Systems, Inc. announced that it has acquired Biolife Delaware, LLC. Under the merger transaction, Biolife has become a wholly owned subsidiary of Merit.

Biolife, headquartered in Sarasota, Florida, manufactures hemostatic devices under the brand names StatSeal and WoundSeal, advised the press release.

According to Merit, StatSeal works with the patient’s blood to rapidly form a protective seal over a percutaneous procedure site. Adding StatSeal to Merit’s hemostasis portfolio is intended to provide health care partners with an additional solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology, dialysis, electrophysiology, biopsy, and drainage.

The aggregate transaction consideration, paid in cash and assumption of Biolife liabilities, was approximately $120 million, stated Merit.

Advertisement

May 20, 2025

Epsilon’s EP-01 Endovascular EEG Device Granted FDA Breakthrough Device Designation

left-arrow Created with Sketch. Previous Article

May 19, 2025

Gradient’s Pulmonary Artery Denervation System Receives FDA Breakthrough Designation

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)